Novo Holdings
Europe, Hovedstaden, Denmark, Hellerup
Description
Novo Holdings is a holding company specializing in life science investor with a focus on creating long-term value.
Investor Profile
Novo Holdings has made 376 investments, with 40 in the past 12 months and 36% as lead.
Stage Focus
- Series A (26%)
- Series B (18%)
- Series C (16%)
- Series Unknown (14%)
- Seed (6%)
- Post Ipo Equity (5%)
- Series D (5%)
- Private Equity (3%)
- Series E (3%)
- Debt Financing (1%)
Country Focus
- United States (47%)
- Denmark (22%)
- United Kingdom (9%)
'%3e%3cpath fill='%23012169' d='M0 0v30h60V0z'/%3e%3cpath stroke='%23fff' stroke-width='6' d='m0 0 60 30m0-30L0 30'/%3e%3cpath stroke='%23C8102E' stroke-width='4' d='m0 0 60 30m0-30L0 30' clip-path='url(%23b)'/%3e%3cpath stroke='%23fff' stroke-width='10' d='M30 0v30M0 15h60'/%3e%3cpath stroke='%23C8102E' stroke-width='6' d='M30 0v30M0 15h60'/%3e%3c/g%3e%3c/svg%3e)
- Switzerland (5%)
- Sweden (3%)
- Germany (3%)
- France (2%)
- Canada (2%)
- Singapore (1%)
'/%3e%3cuse xlink:href='%23a' transform='translate(288.889 -214.211)'/%3e%3cuse xlink:href='%23a' transform='translate(108 342.749)'/%3e%3cuse xlink:href='%23a' transform='translate(469.189 342.749)'/%3e%3c/svg%3e)
- The Netherlands (1%)
Industry Focus
- Biotechnology
- Health Care
- Pharmaceutical
- Medical
- Therapeutics
- Biopharma
- Medical Device
- Life Science
- Health Diagnostics
- Manufacturing
FAQ
Frequently Asked Questions
Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.
'/%3e%3cuse xlink:href='%23a' transform='rotate(23.036 .093 25.536)'/%3e%3cuse xlink:href='%23a' transform='rotate(45.87 1.273 16.18)'/%3e%3cuse xlink:href='%23a' transform='rotate(69.945 .996 12.078)'/%3e%3cuse xlink:href='%23a' transform='rotate(20.66 -19.689 31.932)'/%3e%3c/svg%3e)
